Phibro Animal Health

Phibro Animal Health Reports Strong Q2 FY 2026 Results, Raises Full-Year Guidance

Phibro Animal Health reported strong second-quarter results driven by rapid uptake of its MFA portfolio and continued growth in nutrition and vaccine products, prompting the company to raise its fiscal year 2026 guidance.

Phibro Animal Health Launches Restoris™ Piezoelectric Dental Gel for Dogs

Phibro Animal Health has launched Restoris™, a new piezoelectric dental gel for dogs designed to promote bone growth and restore oral health in cases of periodontal disease.

Topics

Phibro Animal Health Reports Strong Q2 FY 2026 Results, Raises Full-Year Guidance

Phibro Animal Health Launches Restoris™ Piezoelectric Dental Gel for Dogs

Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million, Expanding Precision Animal Health Portfolio

Zoetis to Participate in Bank of America 2026 Animal Health Summit

Tartar Shield Launches ‘Second Smile’ Initiative Integrating Preventive Dental Care Into Shelter Adoptions

Most U.S. Pet Owners Report High Satisfaction with Their Veterinary Practice, AVMA Data Show

FDA Grants Emergency Use Authorization for NexGard Products to Treat New World Screwworm in Dogs and Cats

FDA Approves NUMELVI™, First Second-Generation JAK Inhibitor for Canine Allergic Dermatitis